Epidemiology of adult asthma in Asia: toward a better understanding

Song, Woo Jung; Kang, Min‐Gyu; Chang, Yoon-Seok; Cho, Sang Heon

doi:10.5415/apallergy.2014.4.2.75

Cited by 106 publications

(89 citation statements)

References 54 publications

(97 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Chronic obstructive pulmonary disorder (COPD) is one of the main causes of mortality in Korea 2. The prevalence of asthma, allergic rhinitis (AR), and rhinosinusitis is also increasing and has become the major health priority in Korea 3456. These preventable chronic respiratory diseases have a major adverse impact on quality of life, disability, and productivity, resulting in an increased socioeconomic burden.…”

Section: Introductionmentioning

confidence: 99%

Burden of Respiratory Disease in Korea: An Observational Study on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis

Yoo

Ahn²,

Park

et al. 2016

Allergy Asthma Immunol Res

Self Cite

View full text Add to dashboard Cite

PurposeThe Asia-Pacific Burden of Respiratory Diseases (APBORD) study is a cross-sectional, observational one which has used a standard protocol to examine the disease and economic burden of allergic rhinitis (AR), asthma, chronic obstructive pulmonary disorder (COPD), and rhinosinusitis across the Asia-Pacific region. Here, we report on symptoms, healthcare resource use, work impairment, and associated costs in Korea.MethodsConsecutive participants aged ≥18 years with a primary diagnosis of asthma, AR, COPD, or rhinosinusitis were enrolled. Participants and their treating physician completed a survey detailing respiratory symptoms, healthcare resource use, and work productivity and activity impairment. Costs included direct medical cost and indirect cost associated with lost work productivity.ResultsThe study enrolled 999 patients. Patients were often diagnosed with multiple respiratory disorders (42.8%), with asthma/AR and AR/rhinosinusitis the most frequently diagnosed combinations. Cough or coughing up phlegm was the primary reason for the medical visit in patients with a primary diagnosis of asthma and COPD, whereas nasal symptoms (watery runny nose, blocked nose, and congestion) were the main reasons in those with AR and rhinosinusitis. The mean annual cost for patients with a respiratory disease was US$8,853 (SD 11,245) per patient. Lost productivity due to presenteeism was the biggest contributor to costs.ConclusionsRespiratory disease has a significant impact on disease burden in Korea. Treatment strategies for preventing lost work productivity could greatly reduce the economic burden of respiratory disease.

show abstract

Section: Introductionmentioning

confidence: 99%

Burden of Respiratory Disease in Korea: An Observational Study on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis

Yoo

Ahn²,

Park

et al. 2016

Allergy Asthma Immunol Res

Self Cite

View full text Add to dashboard Cite

show abstract

“…In Asia, which is the most changing population in the world, less than 5% of adults are diagnosed with clinical asthma (4) and in the Eastern Mediterranean region this is between 2.74% and 3.12% (3). Based on the latest report, the prevalence of asthma in the Islamic Republic of Iran was higher than the global rate of disease and is estimated between 5.1% and 7.5% (5,6).…”

Section: Introductionmentioning

confidence: 99%

“…It is defined as physical, emotional, social, material well-being and development, activity functional ability (9). It has become more important with increased life expectancy and changes in the pattern of disease as a result of advancements in medical sciences in order to evaluate cost−utility and cost−effectiveness of health care programs (4).…”

Section: Introductionmentioning

confidence: 99%

Health-related quality of life of patients with asthma: a cross-sectional study in Semnan, Islamic Republic of Iran

Kia

Malek

Ghods

et al. 2017

East Mediterr Health J

View full text Add to dashboard Cite

Qualité de vie liée à la santé de patients asthmatiques : étude transversale à Semnan, République islamique d'IranRÉSUMÉ L'asthme peut affecter gravement la qualité de vie des personnes qui en souffrent. Les données sur la qualité de vie des personnes vivant avec l'asthme en République islamique d'Iran sont en nombre limité. La présente étude transversale avait pour objectif d'évaluer la qualité de vie des adultes asthmatiques à Semnan sur la base du SF-36, un questionnaire court d'enquête sur la santé comprenant 36 items. L'effet des caractéristiques socio-démographiques sur les scores de la qualité de vie a été examiné. L'étude incluait un échantillon de commodité de 385 patients externes souffrant d'asthme et s'étant rendus dans une clinique spécialisée pour les maladies pulmonaires entre juin et décembre 2013. Les scores moyens des composantes physiques et mentales étaient de 58,8 (ET 18,3) et 57,3 (ET 17,0) respectivement. L'échantillon de l'étude affichait des scores inférieurs pour la qualité de vie dans tous les domaines par rapport à la population de référence (p < 0,05). Les patients ayant un niveau d'instruction moindre, les habitants urbains, les patients veufs/divorcés et les travailleurs manuels obtenaient des scores de la qualité de vie plus faibles (p < 0,05). Des efforts sont requis pour améliorer la qualité de vie des patients asthmatiques parallèlement à la mise en place de plans précis pour leur prise en charge. This cross-sectional study aimed to evaluate quality of life in adults with asthma in Semnan using the 36-item short form health survey (SF-36). The effect of sociodemographic characteristics on quality of life scores was examined. The study included a convenience sample of 385 outpatients with asthma attending a pulmonary clinic from June to December 2013. The mean physical and mental component scores were 58.8 (SD 18.3) and 57.3 (SD 17.0) respectively. The study sample had lower quality of life scores in all the fields than the reference population (P < 0.05). Patients with lower education, urban residents, widowed/divorced patients and manual workers had lower quality of life scores (P < 0.05). Efforts are needed to improve the quality of life of people with asthma in parallel with precise management plans. ‫اإلسالمية‬ ‫إيران‬ ‫مجهورية‬ ‫سيمنان،‬‫املتوسط‬ ‫لرشق‬ ‫الصحية‬ ‫املجلة‬ ‫العرشون‬ ‫و‬ ‫الثالث‬ ‫املجلد‬ ‫السابع‬ ‫العدد‬ 501

show abstract

“…The prevalence in the Asian population is 5% lower than in Europe, while in Asia the prevalence of asthma in the elderly is 1.3-15.3%. Temporal trends in prevalence exhibited the recent increase of adult asthma in Hongkong, Japan, and Korea [4]. Asthma in adults often resulted in worsening of lung function and limited air flow.…”

Section: Introductionmentioning

confidence: 99%

Incidence of Hypertension in Asthma Patients Who Treated With Beta-2 Agonists Bronchodilators

Eff

2017

Int J Pharm Pharm Sci

View full text Add to dashboard Cite

Objective: To determine the prevalence of hypertension in hospitalized patients with asthma who were treated with beta-2 agonists. To evaluate the correlation between the duration of the use of beta-2 agonist with the incidence of hypertension.Methods: This research is a descriptive epidemiological, observational cross-sectional and retrospective study design. The study population was all adult asthma patients (age ≥ 25) without a concomitant diseases such as hypertension or metabolic syndrome treated with β2 agonists as a bronchodilator and underwent hospitalized in January 2015-December 2015 (n=108). Patient data were collected from the medical record. Data were analyzed using univariate and bivariate to count the number of occurrences of hypertension and recognizing the correlation between the duration of the use of β2 agonists with hypertension event.Results: The incidence of hypertension in patients with asthma who were treated with beta-2 agonists are 50, 93% at the stage of pre-hypertension (120 mm Hg/80 mm Hg) and 25, 9% in stage I hypertension (140 mmHg/90 mmHg). Body weight and duration of therapy with a β2 agonist positively correlated with the incidence of hypertension with a correlation coefficient (r) 0.231 and 0.386 respectively. Conclusion:In this study, duration of therapy with a β2 agonist in asthma patients positively correlated with the incidence of hypertension.

show abstract

Epidemiology of adult asthma in Asia: toward a better understanding

Cited by 106 publications

References 54 publications

Burden of Respiratory Disease in Korea: An Observational Study on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis

Burden of Respiratory Disease in Korea: An Observational Study on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis

Health-related quality of life of patients with asthma: a cross-sectional study in Semnan, Islamic Republic of Iran

Incidence of Hypertension in Asthma Patients Who Treated With Beta-2 Agonists Bronchodilators

Contact Info

Product

Resources

About